• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LUPIN PHARMACEUTICALS INC. INHALER; NASAL SPRAY, ENT DELIVERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LUPIN PHARMACEUTICALS INC. INHALER; NASAL SPRAY, ENT DELIVERY Back to Search Results
Lot Number IA00269
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 08/07/2024
Type of Reportable Event Serious Injury
Event or Problem Description
A reporter called to submit a report about the defective inhalers he is using from lupin.He said he has been using inhalers for so long for his asthma, but the lupin inhalers do not work.He said when he depresses the equipment nothing comes out.He said he almost died last night from asthma attack because the inhaler did not work.He said at least 10 of them failed.Reference reports: #mw5158133, #mw5158134, #mw5158135, #mw5158136, #mw5158137, #mw5158138, #mw5158139, #mw5158140, #mw5158141.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INHALER
Common Device Name
NASAL SPRAY, ENT DELIVERY
Manufacturer (Section D)
LUPIN PHARMACEUTICALS INC.
harborplace tower,111 s. calvert street
21st floor
baltimore MD 21202
MDR Report Key19938864
Report NumberMW5158142
Device Sequence Number8758683
Product Code KCO
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Voluntary
Initial Reporter Occupation Patient
Type of Report Initial
Report Date (Section B) 08/07/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Expiration Date02/28/2026
Device Lot NumberIA00269
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date08/07/2024
Patient Sequence Number1
Outcome Attributed to Adverse Event Life Threatening;
Patient SexMale
-
-